Is a nephrology referral indicated for a patient with a 19‑mm adrenal adenoma, or should the patient be evaluated by endocrinology first?

Endocrinology Referral, Not Nephrology

A 19-mm adrenal adenoma requires evaluation by endocrinology, not nephrology. Adrenal masses are endocrine disorders requiring hormonal assessment and specialized endocrine management 1.

Why Endocrinology is the Appropriate Specialty

The adrenal glands are endocrine organs that produce cortisol, aldosterone, and catecholamines. Despite their anatomic proximity to the kidneys, adrenal pathology falls squarely within the domain of endocrinology and endocrine surgery 2. Nephrology manages kidney parenchymal disease, electrolyte disorders, and renal replacement therapy—none of which are relevant to an adrenal adenoma unless secondary complications arise.

Required Evaluation Pathway

All patients with adrenal incidentalomas require a structured endocrine workup 1:

Mandatory Hormonal Screening

Every patient must be screened for autonomous cortisol secretion using a 1-mg overnight dexamethasone suppression test, regardless of symptoms 1. This is non-negotiable, as mild autonomous cortisol secretion occurs in 30-50% of incidentalomas and carries significant cardiovascular and metabolic morbidity 3.

Additional Testing Based on Clinical Context

• If hypertension or hypokalemia present: Screen for primary aldosteronism with aldosterone-to-renin ratio 1
• If imaging shows >10 HU on non-contrast CT or any adrenergic symptoms: Screen for pheochromocytoma with plasma or 24-hour urinary metanephrines 1
• If virilization signs present: Test for excess androgens 1

Radiologic Characterization

At 19 mm, this lesion requires proper imaging characterization. If not already done, obtain non-contrast CT to measure Hounsfield units (HU). **Lesions <10 HU are benign adenomas** 2. If >10 HU, proceed with washout CT or chemical-shift MRI 1.

Management Based on Size and Function

Since this lesion is <4 cm and likely benign, the management algorithm is straightforward 2, 1:

• If non-functional and radiologically benign: No further follow-up imaging or functional testing required 1
• If functional: Surgical referral to endocrine surgery for minimally invasive adrenalectomy 1
• If indeterminate: Repeat imaging at 3-6 months 2

Critical Pitfalls to Avoid

Do not refer to nephrology simply because the adrenal gland sits near the kidney. This is a common error that delays appropriate care 4. Even if the patient has concurrent kidney disease, the adrenal mass requires separate endocrine evaluation.

Do not skip hormonal testing even if the patient appears asymptomatic. Up to 47% of initially "non-functional" adenomas become hormonally active over 5 years 2. Subclinical Cushing's syndrome is the most common functional lesion and presents without obvious stigmata 2.

Multidisciplinary Coordination

There should be a low threshold for multidisciplinary review involving endocrinologists, surgeons, and radiologists when imaging is not clearly benign, hormone hypersecretion is present, or surgery is being considered 1. This coordination improves diagnostic accuracy and treatment outcomes 5.

The evidence consistently demonstrates that standardized endocrine evaluation pathways improve completion of biochemical testing and identification of significant disease 5. Nephrology has no role in this pathway unless the patient develops secondary hypertension from aldosterone excess requiring specific management after endocrine diagnosis.